The professor at University Hospital Dresden discussed the positive safety profile of Unicar-T-CD123.
Gerhard Ehninger, MD
Advertisement
Articles by Gerhard Ehninger, MD
The professor at University Hospital Dresden discussed data presented at the 2022 ASH meeting.
Advertisement
Latest Updated Articles
Gerhard Ehninger, MD, on Beneficial Safety in AML With Rapidly Switchable CAR TherapyPublished: December 13th 2022 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Around the Helix: Cell and Gene Therapy Company Updates – October 29, 2025
2
Intellia Puts Phase 3 Trials for Transthyretin Amyloidosis Gene Editing Therapy Nex-Z on Hold Following Grade 4 Liver AE
3
Quarter Century Update: What Lessons Should Guide the Next Generation of Developers and Regulators?
4
Quarter Century Update: What Does the Field Need Most Right Now?
5
